Gene Query: MAGI1

Dataset Description Geneva Score
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 44.99
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 42.52
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 37.18
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 37.18
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 33.56
Crizotinib v. DMSO in SW480 cells 33.07
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 32.33
circRNA-sequencing 29.47
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 29.38
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 28.64
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 28.64
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 28.52
SOX11 knockdown in B-ALL cell lines 27.24
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 27.07
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 26.54
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 26.13
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 25.93
RNA sequencing of BT142 and TS603 cell lines 25.93
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 25.2
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 24.3
U2AF1 mutations alter splice site recognition in hematological malignancies 23.57
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 23.1
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 23.1
Tumor exosome integrins determine organotropic metastasis 22.57
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 22.36
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 20.81
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 20.78
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 20.23
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  19.84
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 19.56
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 19.39
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 19.15
DJ-1 is dispensable for human stem cell homeostasis 19.04
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 18.77
Regulation of hypoxia-inducible factor activity by ZMYND8 18.63
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 18.57
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 17.92
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 17.87
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 17.69
AMPK signaling for naïve pluripotency 17.33
AMPK signaling for naïve pluripotency [Hs] 17.33
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 17.27
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 17.16
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 16.96
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 16.96
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 16.75
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 16.52
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 16.38
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 16.36
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 16.08
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 15.91
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 15.35
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 15.07
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 14.96
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 14.82
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 14.82
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 14.78
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 14.74
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 14.62
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 14.36
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 14.34
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 13.89
Regionally specified human pluripotent stem cell-derived astrocytes 13.87
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 13.64
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 12.87
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 12.8
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 12.69
Differentially expressed vascular development genes for iPSC-ECs from CDI 12.55
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 12.54
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 12.54
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 12.51
RNA-seq analysis of RALD iPSCs after in vitro differentiation 12.5
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 12.5
LncRNA-GAS5 negative regulation of YAP-target genes expression 12.45
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 12.39
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 12.3
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 12.28
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 12.28
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 12.2
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 11.97
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 11.9
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 11.78
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 11.46
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 11.41
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 11.4
RNA-sequencing of human liver tissue 11.4
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 11.32
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 11.27
High-Throughput Kinetic Analysis of Fractional Killing 11.13
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 11.13
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 11.11
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 11.04
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 11.02
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 11.0
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 10.91
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 10.9
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 10.89
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 10.87
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 10.81
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 10.77
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 10.77
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 10.75
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 10.67
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 10.62
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 10.56
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 10.55
Differential gene expression in Jagged1 treated human dental pulp cells. 10.53
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 10.52
RNA-seq of naive and primed ES cells (NHSM) 10.46
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 10.43
RNA sequencing analysis of human embryonic stem cells and axial progenitors 10.12
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 10.1
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 10.09
Genome-wide identification of cancer-specific alternative splicing in circRNA 10.04
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 10.0
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 9.97
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 9.97
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 9.93
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 9.9
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 9.88
Maturation of human iNSCs 9.88
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 9.84
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 9.82
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 9.82
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 9.78
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 9.61
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 9.47
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 9.47
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 9.47
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 9.41
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 9.4
Endothelial gene expression analysis 9.4
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 9.27
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 9.25
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 9.19
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 9.19
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 9.17
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 9.16
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 9.1
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 9.1
Genome-wide functional assessment of enhancer activities in the human genome 9.09
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 9.07
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 9.04
Ebola virus (EBOV) infection of ARPE-19 cells 9.02
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 8.94
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 8.89
MEIS1 regulates hematopoiesis in hPSCs 8.85
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 8.81
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 8.81
ARID1A and ARID1B loss in HCT116 cells 8.81
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 8.81
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 8.79
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 8.61
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 8.61
Cerebellar differentiation in Ataxia-Telangiectasia 8.61
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 8.57
RNA-seq of naive and primed ES cells 8.52
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 8.48
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 8.48
Ectoderm specification of H1 human embryonic stem cells 8.46
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 8.43
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 8.32
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 8.32
Searching for target genes of miR-508/509/506/514 in HCT116 cells 8.3
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 8.24
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 8.21
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 8.19
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 8.17
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 8.15
RNA-Seq from early time points in the kidney differentiation protocol 8.1
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 8.09
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 8.08
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 8.08
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 7.96
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 7.94
Gene expressions of H9s in different culture systems 7.88
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 7.85
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 7.72
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 7.67
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 7.65
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 7.65
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 7.64
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 7.64
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 7.63
iPSC-Derived Cholangiocytes 7.59
Role for citron kinase in prostate cancer growth 7.58
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 7.56
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 7.54
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 7.53
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 7.52
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 7.5
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 7.4
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 7.39
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 7.38
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 7.33
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 7.32
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 7.28
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 7.27
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 7.23
Differential gene expression profiles in imatinib-resistant cell lines 7.19
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 7.18
RNA-seq analysis to identify the genes regulated by p53-SET interplay 7.16
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 7.12
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 7.11
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 7.09
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 7.06
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 7.04
Role of FGFR1 in neuronal devlopment 7.0
SNHG5 siRNA knock down in HCT116 cells 6.99
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 6.98
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 6.97
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 6.91
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 6.91
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 6.88
Spliceosomal disruption of the non-canonical BAF complex in cancer 6.87
The regulartory role of ZCCHC24 in splicing machinery 6.86
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 6.84
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 6.83
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 6.82
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 6.8
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 6.75
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 6.74
LINE-2 transposable elements are a source of functional human microRNAs and target sites 6.7
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 6.69
Noncoding regions are the main source of targetable tumor-specific antigens 6.68
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 6.65
Effect of disulfiram treatment on pediatric high grade glioma 6.64
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 6.63
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 6.63
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 6.58
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 6.56
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 6.56
RNA sequencing of human fibroblasts after SUPT4H1 siRNA treatment 6.55
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 6.51
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 6.5
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 6.42
Transcriptomic analysis of ERR alpha orphan nuclear receptor 6.4
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 6.4
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 6.4
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 6.38
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 6.37
Generation of trichogenic adipose-derived stem cells by expression of three factors 6.36
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 6.34
Global Mapping of Human RNA-RNA Interactions 6.32
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 6.3
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 6.28
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 6.25
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 6.24
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 6.24
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 6.18
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 6.18
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 6.18
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 6.17
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 6.17
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 6.16
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 6.13
Investigation about fibroblasts of different origins in culture 6.05
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 6.02
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 6.01
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 5.96
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 5.92
Selective suppression of endothelial cytokine production by progesterone receptor 5.79
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 5.79
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 5.77
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 5.75
Finding missing proteins from epigenetically manipulated human cells 5.72
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 5.69
The effect of insulin on mRNA transcription of human pluripotent stem cells 5.68
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 5.66
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 5.66
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 5.63
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 5.61
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 5.59
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 5.59
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 5.53
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 5.51
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 5.5
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 5.45
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 5.44
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 5.44
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 5.41
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 5.4
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 5.4
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 5.37
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 5.29
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 5.24
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 5.24
RNA-seq of stable and unstable section of human atherosclerotic plaques 5.23
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 5.22
nELAVL HITS-CLIP in Alzheimer's Disease patients 5.17
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 5.15
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 5.15
Transcriptome sequencing of K-562 cells 5.15
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 5.11
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 5.09
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 5.09
Random mono-allelic expression in MECP2-mutated cells 5.09
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 5.08
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 5.02
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 5.0
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 5.0
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 4.99
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 4.95
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 4.91
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 4.9
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 4.89
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 4.88
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 4.85
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 4.8
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 4.77
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 4.75
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 4.75
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 4.74
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 4.66
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 4.66
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 4.65
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 4.6
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 4.53
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 4.48
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 4.48
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 4.43
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 4.43
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 4.43
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 4.43
Capturing the Interactome of Newly Transcribed RNA (RICK) 4.36
Capturing the Interactome of Newly Transcribed RNA 4.36
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 4.34
Gene expression profile in breast cancer cells 4.34
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 4.3
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 4.29
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 4.25
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 4.2
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 4.18
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 4.18
Entrectinib Resistance in a Neuroblastoma Xenograft Model 4.15
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 4.14
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 4.14
ARID1A and ARID1B loss in HCT116 and TOV21G cells 4.13
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 4.13
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 4.03
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 4.03
JAK dependent survival of ALK- ALCL 3.94
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 3.91
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 3.89
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 3.88
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 3.87
Disruption of GRIN2B impairs differentiation in human neurons 3.83
Molecular Criteria for Defining the Naive Human Pluripotent State 3.77
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 3.74
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 3.7
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 3.7
Deep RNA sequencing of the human placental transcriptome 3.7
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 3.69
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 3.69
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 3.63
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 3.51
Epigenome regulation during epidermal lineage commitment [RNA-seq] 3.5
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 3.43
RNA Sequencing of three pairs of gastric cancer 3.41
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 3.35
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 3.33
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 3.28
Expression profiling of MCF-7 cells with treatment of TCDD 3.28
Novel Targeting of Transcription and Metabolism in Glioblastoma 3.24
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 3.18
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 3.18
RNA-seq of MDA-MB-231 cells with TET1 knockout 3.17
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 3.17
Effect of PBK knockdown on C4-2 cell transcriptome 3.01
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 3.0
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 2.99
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 2.95
Gene expression profile in breast cancer cell lines using RNA sequencing 2.91
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 2.89
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 2.89
Gene expression profile of CRC-derived HILEC 2.89
Nonpregnant and term pregnant human myometrial tissues 2.85
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 2.85
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 2.83
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 2.81
STX4 Over-Expression in Human islets 2.79
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 2.78
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 2.76
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 2.74
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 2.7
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 2.7
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 2.64
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 2.64
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 2.6
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 2.6
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 2.59
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 2.57
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 2.53
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 2.5
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 2.47
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 2.42
MARS Seq data from human cortical organoids 2.42
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 2.39
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 2.39
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 2.34
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 2.34
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 2.3
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 2.29
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 2.27
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 2.2
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 2.2
Single-cell analysis of adult human ovary using 10X genomics 2.17
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 2.15
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 2.15
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 2.06
RNA seq_PDX2_SHP099 2.04
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 2.02
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 1.99
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 1.93
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 1.91
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 1.84
Primate-specific gene TMEM14B promotes cortical expansion and folding 1.77
MRTF activates TEAD-YAP target gene expression 1.75
The chromatin modifier CHD8 targets autism risk genes during human neurodevelopment  1.74
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 1.68
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 1.64
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 1.64
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 1.6
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 1.58
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 1.51
RNA sequencing of human pancreatic cancer cell lines 1.5
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 1.49
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 1.39
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 1.36
The gene expression profiles of gallbladder cancer 1.31
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 1.25
RNA sequencing analysis of selumetinib-resistant CRC cells lines 1.23
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 1.2
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 1.2
Dermal endothelial cells of type 2 diabetic patients 1.18
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 1.16
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 1.13
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 1.12
Illumina HiSeq Sequencing on Breast cancer PDX samples 1.11
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 1.09
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 1.07
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 1.05
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 1.01
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 0.99
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 0.98
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 0.97
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 0.96
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.95
Persistence of stem cell metabolism in cancers as a failure of differentiation 0.94
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 0.93
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 0.91
Non-coding regions are the main source of tumor-specific antigens [human] 0.91
Non-coding regions are the main source of tumor-specific antigens 0.91
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 0.87
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.82
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 0.8
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 0.8
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.79
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 0.79
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.76
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.73
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 0.7
Changes in human endometrial gland transcriptome over the window of implantation 0.66
Transcriptomes in healthy and CHB fetal hearts 0.63
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 0.62
Gene expression profile of human placenta from T. Cruzi infected mothers 0.59
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 0.58
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.57
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.54
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.54
Gene expression of collecting duct carcinoma of the kidney 0.5
Preclinical model of obesity and ER-positive breast cancer 0.43
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.41
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.41
RNAseq analysis of ruxolitinib treated breast cancers 0.37
Functional astrocytes differentiated from hiPSCs 0.35
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.34
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.34
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 0.33
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.28
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 0.26
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 0.24
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 0.24
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.24
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 0.21
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 0.2
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.17
BMS-470539 on human synovial fibroblasts 0.14
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 0.14
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 0.14
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.12
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.12
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 0.06
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 0.04
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.02
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.02
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 0.01
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 0.01
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 0.01
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation